Coronary Artery Disease Top Open Access Journals
The clinical definition of shock is decreased flow and evidence of tissue hypoxia within the presence of adequate intravascular volume. Shock is that the leading explanation for death in acute myocardial infarction (MI), with mortality rates as high as 70-90% within the absence of aggressive, highly experienced technical care. Cardiogenic shock (CS) may be a common explanation for mortality, and management remains challenging despite advances in therapeutic options. Cardiogenic shock is caused by severe impairment of myocardial performance that results in diminished cardiac output, end‐organ hypoperfusion, and hypoxia. Clinically this presents as hypotension refractory to volume resuscitation with features of end‐organ hypoperfusion requiring pharmacological or mechanical intervention. Acute myocardial infarction (MI) accounts for 81% of patient in Cardiogenic shock, The blockage of the arteries and Blood vessels which provide oxygen and nutrient rich blood to heart. It is also called coronary heart disease and is the leading cause of death in humans. This occurs when the coronary arteries become blocked or clogged, often this leads to an irregular heartbeat - called an arrhythmia - that causes a severe decrease in the pumping function of the heart. A blockage that's not treated within a couple of hours causes the affected cardiac muscle to die.
High Impact List of Articles
-
Market Analysis for 11th World Heart Congress
Subbiah RamasamyEditorial: Current Trends in Cardiology
-
Comparison of the two dimensional versus three dimensional transthoracic echocardiography in assessment of mitral regurgitation.
Kovitu TyugoResearch Article: Current Trends in Cardiology
-
It?s time to focus on decreasing cardiovascular mortality in NAFLD
population: potential use of statins and PCSK9 inhibitors.
Tarek Ajam, Anuj Chhaparia, Zachary Oman, Ali MehdiradReview Article: Current Trends in Cardiology
-
Angioplasty with drug-eluting stents versus bypass grafting for treatment of
unprotected left main stem disease.
Ramlall M, Costanzo P, Ali A and John JShort Communication: Current Trends in Cardiology
-
Genetics of coronary artery disease
Fan WangEditorial: Current Trends in Cardiology
Conference Proceedings
-
Coronary artery bypass surgery or interventional cardiology? Why not both? Let’s go for hybrid coronary revascularization
Khalida SoomroPosters & Accepted Abstracts: Current Trends in Cardiology
-
HIGH RATE OF BREAST CANCER IN CATANIA: OUR EXPERIENCE
Marta Noemi Monari, C Belgiovine, L Paravizzini, L Gullotti, G Falzone and F ZangrandiScientific Tracks Abstracts: Research and Reports in Gynecology and Obstetrics
-
HIGH RATE OF BREAST CANCER IN CATANIA: OUR EXPERIENCE
Marta Noemi Monari, C Belgiovine, L Paravizzini, L Gullotti, G Falzone and F ZangrandiScientific Tracks Abstracts: Research and Reports in Gynecology and Obstetrics
-
CHILDHOOD OBESITY
Horia Al MawlawiScientific Tracks Abstracts: Biomedical Research
-
CHILDHOOD OBESITY
Horia Al MawlawiScientific Tracks Abstracts: Biomedical Research
-
SUSTAINABLE GRAPHENE - BASED NANOCOMPOSITES FOR VEHICLE STRUCTURES
Ahmed ElmarakbiPosters & Accepted Abstracts: Biomedical Research
-
SUSTAINABLE GRAPHENE - BASED NANOCOMPOSITES FOR VEHICLE STRUCTURES
Ahmed ElmarakbiPosters & Accepted Abstracts: Biomedical Research
-
Mutagenic and Cytotoxic Effects of Doxorubicin (Adriamycin) and Epeirubicin, Common Anthracycline DNA II Topoisomerase Inhibitors Used Against Breast Cancer, in Prokaryotic and Eukaryotic Cells
William J MackayPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics
-
Mutagenic and Cytotoxic Effects of Doxorubicin (Adriamycin) and Epeirubicin, Common Anthracycline DNA II Topoisomerase Inhibitors Used Against Breast Cancer, in Prokaryotic and Eukaryotic Cells
William J MackayPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics